0QFP Stock Overview Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
Rewards Risk Analysis See All Risk Checks Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Competitors Price History & Performance
Summary of all time highs, changes and price drops for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt Historical stock prices Current Share Price Ft10,949.88 52 Week High Ft11,104.66 52 Week Low Ft8,510.60 Beta 0.37 11 Month Change 1.16% 3 Month Change n/a 1 Year Change 25.10% 33 Year Change 23.45% 5 Year Change 100.92% Change since IPO 192.78%
Recent News & Updates
Second quarter 2024 earnings released: EPS: Ft383 (vs Ft155 in 2Q 2023) Aug 07
Investor sentiment deteriorates as stock falls 45% Jun 18
Upcoming dividend of Ft423 per share May 29
High number of new directors May 16
First quarter 2024 earnings released: EPS: Ft373 (vs Ft210 in 1Q 2023) May 15
Dividend of Ft423 announced Apr 29 See more updates
Second quarter 2024 earnings released: EPS: Ft383 (vs Ft155 in 2Q 2023) Aug 07
Investor sentiment deteriorates as stock falls 45% Jun 18
Upcoming dividend of Ft423 per share May 29
High number of new directors May 16
First quarter 2024 earnings released: EPS: Ft373 (vs Ft210 in 1Q 2023) May 15
Dividend of Ft423 announced Apr 29
High number of new directors Apr 11
Full year 2023 earnings released: EPS: Ft860 (vs Ft907 in FY 2022) Apr 06
Full year 2023 earnings released: EPS: Ft860 (vs Ft835 in FY 2022) Mar 02
Investor sentiment deteriorates as stock falls 43% Dec 28
Investor sentiment deteriorates as stock falls 43% Dec 12
Investor sentiment deteriorates as stock falls 42% Nov 27
Third quarter 2023 earnings released: EPS: Ft294 (vs Ft442 in 3Q 2022) Nov 11
Now 42% undervalued after recent price drop Nov 09
Investor sentiment deteriorates as stock falls 41% Nov 06
European Commission Approves the Commercialisation of RYEQO® for the Symptomatic Treatment of Endometriosis Nov 04 Gedeon Richter Plc., Sumitomo Pharma America, Inc. and Sumitomo Pharma Switzerland, GmbH Receives European Commission grant for Commercialisation of RYEQO®
Now 43% undervalued after recent price drop Oct 25
Investor sentiment deteriorates as stock falls 42% Oct 20
Now 44% undervalued after recent price drop Oct 06
Investor sentiment deteriorates as stock falls 45% Sep 26
Now 45% undervalued after recent price drop Sep 19
Gedeon Richter and Sumitomo Pharma Receives Positive Chmp Opinion for Ryeqo(R) for Treatment of Endometriosis Sep 17
Gedeon Richter and Sumitomo Pharma Receives Positive Chmp Opinion for Ryeqo(R) for Treatment of Endometriosis Sep 16
Investor sentiment deteriorates as stock falls 43% Sep 08
Now 49% undervalued after recent price drop Aug 15
New minor risk - Earnings quality Aug 07
Second quarter 2023 earnings released: EPS: Ft155 (vs Ft411 in 2Q 2022) Aug 06
Now 42% undervalued after recent price drop Jul 28
Investor sentiment deteriorates as stock falls 42% Jul 24
Now 43% undervalued Jul 12
Investor sentiment deteriorates as stock falls 40% Jul 07
Now 43% undervalued after recent price drop Jun 23
Investor sentiment deteriorates as stock falls 40% Jun 21
Now 43% undervalued after recent price drop Jun 08
Investor sentiment deteriorates as stock falls 40% Jun 05
Upcoming dividend of Ft390 per share at 4.5% yield May 31
Now 44% undervalued May 24
Investor sentiment deteriorates as stock falls 40% May 19
First quarter 2023 earnings released: EPS: Ft210 (vs Ft199 in 1Q 2022) May 14
Now 44% undervalued May 09
Investor sentiment deteriorates as stock falls 37% Apr 28
Now 47% undervalued Apr 21
Investor sentiment deteriorates as stock falls 35% Apr 12
Full year 2022 earnings released Apr 07
Investor sentiment deteriorates as stock falls 33% Mar 22
Now 32% undervalued after recent price drop Mar 09
Investor sentiment deteriorates as stock falls 35% Feb 28
Now 33% undervalued after recent price drop Feb 17
Investor sentiment deteriorates as stock falls 38% Feb 13
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER) acquired OC Distributors Ltd from Consilient Health for £32.5 million. Feb 09
Now 31% undervalued after recent price drop Feb 02
Investor sentiment deteriorated over the past week Jan 21
Now 33% undervalued after recent price drop Jan 18
Investor sentiment deteriorated over the past week Jan 04
Now 39% undervalued after recent price drop Jan 03
Investor sentiment deteriorated over the past week Dec 20
Now 54% undervalued after recent price drop Dec 16 Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. to Report Q1, 2023 Results on May 12, 2023
Investor sentiment deteriorated over the past week Dec 05
Investor sentiment deteriorated over the past week Nov 18
No independent directors Nov 16
Investor sentiment deteriorated over the past week Oct 24
Investor sentiment deteriorated over the past week Oct 01
Investor sentiment deteriorated over the past week Sep 12
Investor sentiment deteriorated over the past week Aug 25
Investor sentiment deteriorated over the past week Aug 10
Second quarter 2022 earnings released: EPS: Ft411 (vs Ft151 in 2Q 2021) Aug 05
Investor sentiment deteriorated over the past week Jul 23
Investor sentiment deteriorated over the past week Jul 07
Investor sentiment deteriorated over the past week Jun 15
Upcoming dividend of Ft225 per share Jun 01
Investor sentiment deteriorated over the past week May 26
Investor sentiment deteriorated over the past week May 11
No independent directors Apr 27
Investor sentiment deteriorated over the past week Apr 08
Investor sentiment deteriorated over the past week Mar 10
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Mar 05
Investor sentiment deteriorated over the past week Feb 17
Investor sentiment deteriorated over the past week Feb 02
Investor sentiment deteriorated over the past week Jan 18
Investor sentiment deteriorated over the past week Dec 20
Investor sentiment deteriorated over the past week Dec 03
Investor sentiment deteriorated over the past week Nov 17
Third quarter 2021 earnings released: EPS Ft205 (vs Ft121 in 3Q 2020) Nov 10
Investor sentiment deteriorated over the past week Oct 22
Investor sentiment deteriorated over the past week Sep 30
No independent directors Sep 14
Second quarter 2021 earnings released: EPS Ft151 (vs Ft170 in 2Q 2020) Aug 05
Investor sentiment deteriorated over the past week Jun 24
Investor sentiment deteriorated over the past week Jun 07 Shareholder Returns 0QFP GB Pharmaceuticals GB Market 7D -0.04% -4.4% -1.3% 1Y 25.1% 5.6% 8.9%
See full shareholder returns
Return vs Market: 0QFP exceeded the UK Market which returned 8.9% over the past year.
Price Volatility Is 0QFP's price volatile compared to industry and market? 0QFP volatility 0QFP Average Weekly Movement n/a Pharmaceuticals Industry Average Movement 6.8% Market Average Movement 4.7% 10% most volatile stocks in GB Market 9.5% 10% least volatile stocks in GB Market 2.6%
Stable Share Price: 0QFP's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine 0QFP's volatility change over the past year.
About the Company Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. researches, develops, manufactures, markets, and sells pharmaceutical products worldwide. It operates through two segments, Pharmaceuticals, and Wholesale and Retail.
Show more Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Fundamentals Summary How do Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's earnings and revenue compare to its market cap? 0QFP fundamental statistics Market cap Ft1.97t Earnings (TTM ) Ft229.13b Revenue (TTM ) Ft811.42b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 0QFP income statement (TTM ) Revenue Ft811.42b Cost of Revenue Ft260.03b Gross Profit Ft551.39b Other Expenses Ft322.26b Earnings Ft229.13b
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 12, 2024
Earnings per share (EPS) 1.26k Gross Margin 67.95% Net Profit Margin 28.24% Debt/Equity Ratio 9.4%
How did 0QFP perform over the long term?
See historical performance and comparison Dividends
4.0% Current Dividend Yield
